000 01483 a2200469 4500
005 20250511185113.0
264 0 _c19930115
008 199301s 0 0 eng d
022 _a0041-1345
040 _aNLM
_beng
_cNLM
100 1 _aKonertz, W
245 0 0 _aIs pretransplant antiarrhythmic drug therapy a risk factor?
_h[electronic resource]
260 _bTransplantation proceedings
_cDec 1992
300 _a2677-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAmiodarone
_xadministration & dosage
650 0 4 _aAnti-Arrhythmia Agents
_xadministration & dosage
650 0 4 _aAprindine
_xadministration & dosage
650 0 4 _aCause of Death
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHeart Transplantation
_xmortality
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMexiletine
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aPostoperative Complications
_xmortality
650 0 4 _aPremedication
650 0 4 _aPropafenone
_xadministration & dosage
650 0 4 _aQuinidine
_xadministration & dosage
650 0 4 _aSotalol
_xadministration & dosage
650 0 4 _aSurvival Rate
650 0 4 _aTransplantation, Heterotopic
_xmortality
700 1 _aWeyand, M
700 1 _aDeiwick, M
700 1 _aScheld, H H
773 0 _tTransplantation proceedings
_gvol. 24
_gno. 6
_gp. 2677-8
999 _c1472384
_d1472384